Fundraising FoxAxsome Therapeutics
NASDAQ: AXSMNew York, US · Founded 2012 · Delaware corporation
Find your way into Axsome Therapeutics
Sign up to see every warm intro you have to Axsome Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axsome Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Axsome Therapeutics is a biopharmaceutical company. The available page content is only an external-link disclaimer and does not describe the company's products or activities in detail.
Founders & leadership
Axsome Therapeutics was founded in 2012 by Herriot Tabuteau.
Reported raises · per SEC filings
Form D private placements$5.8M disclosed across 3 rounds · 2014–2015
▶$2.5MraisedMay 2015 · 14 investors · PharmaceuticalsRule 506(b)
- Herriot TabuteauExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.3MraisedJan 2015 · 4 investors · PharmaceuticalsRule 506(b)
- Herriot TabuteauExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$2MraisedSep 2014 · 12 investors · PharmaceuticalsRule 506(b)
- Herriot TabuteauExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $2M
- Minimum investment
- $25K
- Sales commissions
- $500K
- Placement agents
- Brookline Group, LLC
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Axsome Therapeutics went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Axsome Therapeutics.
In the news
Frequently asked questions
- What does Axsome Therapeutics do?
- Axsome Therapeutics is a biopharmaceutical company. The available page content is only an external-link disclaimer and does not describe the company's products or activities in detail.
- Who founded Axsome Therapeutics?
- Axsome Therapeutics was founded by Herriot Tabuteau in 2012.
- How much funding has Axsome Therapeutics raised?
- Axsome Therapeutics has disclosed $5.8M raised across 3 rounds.
- Where is Axsome Therapeutics headquartered?
- Axsome Therapeutics is headquartered in New York, US.